France Bed HoldingsLtd Past Earnings Performance
Past criteria checks 5/6
France Bed HoldingsLtd has been growing earnings at an average annual rate of 8.1%, while the Healthcare industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 3.5% per year. France Bed HoldingsLtd's return on equity is 8.3%, and it has net margins of 5.3%.
Key information
8.1%
Earnings growth rate
10.4%
EPS growth rate
Healthcare Industry Growth | 7.9% |
Revenue growth rate | 3.5% |
Return on equity | 8.3% |
Net Margin | 5.3% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How France Bed HoldingsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 60,035 | 3,210 | 27,825 | 0 |
30 Jun 24 | 59,997 | 3,171 | 27,614 | 0 |
31 Mar 24 | 59,151 | 3,134 | 27,302 | 0 |
31 Dec 23 | 58,705 | 2,636 | 27,288 | 0 |
30 Sep 23 | 58,700 | 2,712 | 27,093 | 0 |
30 Jun 23 | 58,782 | 2,774 | 26,861 | 0 |
31 Mar 23 | 58,578 | 2,702 | 26,713 | 0 |
31 Dec 22 | 57,554 | 2,544 | 26,393 | 0 |
30 Sep 22 | 56,664 | 2,491 | 26,021 | 0 |
30 Jun 22 | 55,392 | 2,349 | 25,645 | 0 |
31 Mar 22 | 54,398 | 2,557 | 25,081 | 0 |
31 Dec 21 | 54,113 | 2,625 | 24,763 | 0 |
30 Sep 21 | 54,010 | 2,749 | 24,499 | 0 |
30 Jun 21 | 54,051 | 2,778 | 24,290 | 0 |
31 Mar 21 | 52,430 | 2,295 | 23,792 | 0 |
31 Dec 20 | 51,205 | 1,958 | 23,302 | 0 |
30 Sep 20 | 50,499 | 1,705 | 23,118 | 0 |
30 Jun 20 | 51,194 | 1,545 | 23,118 | 0 |
31 Mar 20 | 52,430 | 1,520 | 23,425 | 0 |
31 Dec 19 | 52,755 | 2,910 | 23,493 | 0 |
30 Sep 19 | 52,797 | 2,576 | 23,413 | 0 |
30 Jun 19 | 51,646 | 2,425 | 23,264 | 0 |
31 Mar 19 | 51,764 | 2,599 | 23,128 | 0 |
31 Dec 18 | 52,333 | 1,579 | 23,133 | 0 |
30 Sep 18 | 52,207 | 1,744 | 23,028 | 0 |
30 Jun 18 | 52,529 | 1,900 | 22,922 | 0 |
31 Mar 18 | 52,410 | 1,806 | 22,828 | 0 |
31 Dec 17 | 52,306 | 2,200 | 22,790 | 0 |
30 Sep 17 | 52,241 | 2,097 | 22,859 | 0 |
30 Jun 17 | 52,051 | 1,887 | 22,798 | 0 |
31 Mar 17 | 52,126 | 1,931 | 22,756 | 0 |
31 Dec 16 | 52,008 | 1,202 | 22,703 | 0 |
30 Sep 16 | 52,377 | 1,331 | 22,564 | 0 |
30 Jun 16 | 52,549 | 1,384 | 22,440 | 0 |
31 Mar 16 | 52,644 | 1,402 | 22,310 | 0 |
31 Dec 15 | 52,860 | 1,364 | 22,195 | 0 |
30 Sep 15 | 52,609 | 1,188 | 22,192 | 0 |
30 Jun 15 | 52,077 | 1,033 | 22,241 | 0 |
31 Mar 15 | 51,907 | 904 | 22,291 | 0 |
31 Dec 14 | 53,422 | 1,004 | 22,396 | 0 |
30 Sep 14 | 54,203 | 1,143 | 22,304 | 0 |
30 Jun 14 | 54,608 | 1,315 | 22,073 | 0 |
31 Mar 14 | 54,891 | 1,397 | 21,939 | 0 |
31 Dec 13 | 52,728 | 1,288 | 21,479 | 0 |
Quality Earnings: 7840 has high quality earnings.
Growing Profit Margin: 7840's current net profit margins (5.3%) are higher than last year (4.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7840's earnings have grown by 8.1% per year over the past 5 years.
Accelerating Growth: 7840's earnings growth over the past year (18.4%) exceeds its 5-year average (8.1% per year).
Earnings vs Industry: 7840 earnings growth over the past year (18.4%) exceeded the Healthcare industry 5.1%.
Return on Equity
High ROE: 7840's Return on Equity (8.3%) is considered low.